COVID-19 Vaccine Information For CUIMC Employees and Students

The Pfizer/BioNTech and Moderna COVID-19 vaccines are currently being administered to front-line health care personnel at CUIMC. A prioritized roll-out of the vaccine will continue in the weeks and months ahead for all CUIMC faculty, staff and students. 

All employees and students must continue to take the appropriate precautions, including masking, appropriate PPE, and social distancing to limit the spread of COVID-19.

Please continue to check this page for updates.

Vaccination Updates and Announcements

COVID-19 Vaccinations FAQ

CUIMC Vaccine Committee

Interim EVP and Dean Anil Rustgi, MD, has appointed a committee to address a range of issues related to COVID-19 vaccines. The committee, which is being co-chaired by Magda Sobieszczyk, MD, and Melissa Stockwell, MD MPH, will address the following:

  • Understand and assist in the equitable distribution of vaccines in the outpatient setting for faculty, staff, and trainees who are not in frontline emergency department and inpatient clinical roles. The committee’s work will complement the work of a University-wide vaccine committee and an NYP committee, both of which include membership from CUIMC. The NYP vaccine committee is addressing vaccine distribution to frontline health care workers. Both the CUIMC and NYP committees will also address the distribution of vaccines to patients in inpatient and outpatient settings.
  • Help disseminate information and identify potential educational opportunities to increase vaccine confidence among faculty, staff, and trainees.
  • Prioritize clinical trials of COVID-19 vaccines and therapeutics.
  • Understand the ethical and mental health implications related to the roll-out of COVID-19 vaccines. 
  • Understand the needs of the local community and potential risks related to health care disparities.
  • Pursue areas that the committee identifies, including needs related to research and education.

Committee Members are:

  • Lou Baptista, MD Associate Professor of Psychiatry, Vice Chair for Clinical Services 
  • Ansgar Brambrink, MD, PhD Chair, Department of Anesthesiology
  • Jack Cioffi, MD Chair, Department of Ophthalmology 
  • Lydia Dugdale, MD, MAR Associate Professor of Medicine, Director, Center for Clinical Medicine Ethics 
  • Dustin T. Duncan, ScD, Associate Professor, Mailman School of Public Health
  • Stephen A. Ferrara, RN, DNP, FNP-BC, Associate Dean of Clinical Affairs, School of Nursing 
  • Regine Grandmougin, Senior Executive Director, Patient Facilitated Services and Stewardship 
  • Andrew Lassman, MD, Associate Professor of Neurology and Chief of Neuro-Oncology 
  • Donna Lynne, DrPH, Senior Vice President and Chief Operating Officer of CUIMC, Chief Executive Officer ColumbiaDoctors 
  • James McKiernan, MD, Chair, Department of Urology 
  • Rudina Odeh-Ramadan, PharmD, Vice Dean for Finance and Administration 
  • Biana Roykh, DDS, MPH, Senior Associate Dean for Clinical Affairs, College of Dental Medicine 
  • Steven Shea, MD, MS, Senior Vice Dean, Professor of Medicine and Epidemiology in Biomedical Informatics
  • Magda Sobieszczyk, MD, MPH, Associate Professor of Medicine, Chief of Infectious Diseases 
  • Melissa Stockwell, MD, MPH, Associate Professor of Pediatrics and Population Family Health, Chief of Child Adolescent Health
  • Olajide Williams, MD, MS, Professor of Neurology, Chief of Staff, Department of Neurology

New York State Eligibility

Vaccines are being distributed in accordance with New York State guidelines, which establish phased distribution based on need and risk. Under New York guidelines, those eligible for the vaccine as of January 12th, 2021 are in groups 1a and 1b. Please see the State's Phased Distribution Eligibility for more information.

Town Hall Recordings